Recombinant protein of human tumor necrosis factor (TNF superfamily, member 2) (TNF), 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Products
Lenti ORF clone of Human tumor necrosis factor (TNF), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
CNY 3990.00
2周
CNY 3990.00
2周
TNF - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Transient overexpression of TNF in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Purified recombinant protein of Human tumor necrosis factor (TNF) mutant, tag free, expressed in E.Coli, 50 ug
| Tag | Tag Free |
| Expression Host | E. coli |
TNF mouse monoclonal antibody, clone OTI1D9 (formerly 1D9)
| Applications | IHC, WB |
| Reactivities | Human |
TNF - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
TNF mouse monoclonal antibody, clone OTI1H3 (formerly 1H3)
| Applications | FC, WB |
| Reactivities | Human |
Recombinant protein of human Tumor Necrosis Factor-a (TNFa) produced in E. coli.
| Tag | Tag-free |
| Expression Host | E. coli |
TNF MS Standard C13 and N15-labeled recombinant protein (NP_000585)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
Rabbit polyclonal anti-TNFA antibody
| Applications | IF, IHC |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Tags
Vectors
Reporters
Conjugates
Isotypes
Clonalities
Mutants
Assay Types
QC Levels
Families
Pathways
- Adipocytokine signaling pathway (62)
- Allograft rejection (62)
- Alzheimer's disease (62)
- Amyotrophic lateral sclerosis (ALS) (62)
- Apoptosis (62)
- Asthma (62)
- Cytokine-cytokine receptor interaction (62)
- Dilated cardiomyopathy (62)
- Fc epsilon RI signaling pathway (62)
- Graft-versus-host disease (62)
- Hematopoietic cell lineage (62)
- Hypertrophic cardiomyopathy (HCM) (62)
- MAPK signaling pathway (62)
- NOD-like receptor signaling pathway (62)
- Natural killer cell mediated cytotoxicity (62)
- RIG-I-like receptor signaling pathway (62)
- Systemic lupus erythematosus (62)
- T cell receptor signaling pathway (62)
- TGF-beta signaling pathway (62)
- Toll-like receptor signaling pathway (62)
- Type I diabetes mellitus (62)
- Type II diabetes mellitus (62)
